MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 136 filers reported holding MERSANA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $7,946,920 | -29.1% | 2,415,477 | -18.5% | 0.06% | -26.9% |
Q1 2023 | $11,208,385 | -29.0% | 2,962,848 | +10.0% | 0.08% | -26.4% |
Q4 2022 | $15,779,351 | -6.6% | 2,692,848 | +7.8% | 0.11% | -10.9% |
Q3 2022 | $16,886,000 | +83.6% | 2,497,848 | +25.5% | 0.12% | +56.6% |
Q2 2022 | $9,196,000 | +24.9% | 1,990,559 | +7.9% | 0.08% | +52.0% |
Q1 2022 | $7,360,000 | -41.5% | 1,844,823 | -8.8% | 0.05% | -37.5% |
Q4 2021 | $12,582,000 | -34.0% | 2,022,895 | 0.0% | 0.08% | -38.5% |
Q3 2021 | $19,075,000 | -28.8% | 2,022,895 | +2.5% | 0.13% | -29.0% |
Q2 2021 | $26,792,000 | -6.6% | 1,972,895 | +75.8% | 0.18% | -23.4% |
Q1 2021 | $28,682,000 | -3.9% | 1,122,173 | +0.0% | 0.24% | +1.3% |
Q4 2020 | $29,861,000 | +172.9% | 1,122,145 | +90.9% | 0.24% | +129.1% |
Q3 2020 | $10,943,000 | -21.5% | 587,708 | -1.3% | 0.10% | -29.9% |
Q2 2020 | $13,941,000 | +2354.4% | 595,743 | +1554.8% | 0.15% | +1370.0% |
Q1 2018 | $568,000 | +188.3% | 36,000 | +200.0% | 0.01% | +233.3% |
Q4 2017 | $197,000 | – | 12,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |